Climb Bio Inc (CLYM)
Healthcare
Biotechnology
11.90 $
-1.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Climb Bio Inc (CLYM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -14 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.0 | 3.5 | -0.9 | -1.8 | -0.7 | -7.6 | -5.5 | -15 | -11 | -12 | -16 | -14 | -53 | |
| – | – | – | – | – | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.8 | 0.7 | 1.2 | 0.5 | 0.5 | 2.9 | 1.7 | 2.0 | 1.0 | 4.0 | 1.0 | 1.6 | 7.6 | |
| -2.7 | 7.5 | 1.4 | -0.6 | 2.0 | -1.3 | 1.7 | 3.9 | -3.0 | -2.8 | 1.3 | -2.1 | -6.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.2 | |
| -1.6 | 28 | 37 | 14 | -9.6 | -72 | -53 | -43 | 4.8 | 15 | 26 | -13 | 33 | |
| 0.0 | 0.5 | 0.3 | 0.0 | 128 | 2.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -9.1 | 32 | 36 | 12 | 118 | -77 | -59 | -58 | -6.3 | 3.1 | 9.9 | -27 | -21 | |
| -8.0 | 3.5 | -0.9 | -1.8 | -0.7 | -7.6 | -5.5 | -15 | -11 | -12 | -16 | -14 | -53 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.